期刊文献+

2012年重庆市细菌耐药性监测 被引量:15

The bacterial resistance surveillance of Chongqing in 2012
暂未订购
导出
摘要 目的了解重庆市主要医院临床分离菌对常用抗菌药物的敏感性和耐药性。方法重庆市34所医院(包括一所儿童医院)临床分离菌采用MIC法及K-B法按统一方案进行细菌药物敏感试验,结果按CLSI 2012年版标准判断。结果 2012年1月至12月共收集重庆市临床分离菌共49636株,其中革兰阳性菌占26.6%,革兰阴性菌占73.4%。金葡菌和凝固酶阴性葡萄球菌中甲氧西林耐药株(MRSA和MRCNS)分别为26.9%和72.2%。葡萄球菌属中甲氧西林耐药株对β-内酰胺类抗生素和其他测试药的耐药率显著高于甲氧西林敏感株,未发现万古霉素和利奈唑胺耐药株。肠球菌属中粪肠球菌对多数测试药物的耐药率低于屎肠球菌,两者中均有少数万古霉素耐药株和利奈唑胺耐药株。非脑膜炎肺炎链球菌PISP和PRSP比例较高,未发现万古霉素耐药株。大肠埃希菌、肺炎克雷伯菌中产ESBLs株分别为59.9%和30.9%。肠杆菌科细菌对碳青霉烯类抗生素仍高度敏感,总耐药率小于1.0%。铜绿假单胞菌对亚胺培南和美罗培南耐药率分别为20.2%和18.2%,鲍曼不动杆菌对两者的耐药率分别为52.1%和48.3%。多重耐药肺炎克雷伯菌和鲍曼不动杆菌增加明显。结论细菌耐药性严重,尤其是多重耐药菌对临床构成严重威胁。合理选用抗菌药,加强感染控制措施是当务之急。 Objective To investigate the susceptibility and resistance of clinical isolates from major hospitals of Chongqing. Methods 34 hospitals were involved in this program. Bacterial susceptibility testing was carried out using MIC and Kirby-Bauer method. Results were analyzed according to CLSI 2012. Results A total of 49,636 clinical isolates were collected from January to December 2012, of which Gram negative organisms and Gram positive organisms accounted for 73.4% and 26.6%, respectively. Methicillin resistant strains in S. aureus (MRSA) and coagulase negative Staphylococcus (MRCNS) accounted for 26.9% and 72.2%, respectively. The resistance rates of MR strains to β-lactams and other antimicrobial agents were much higher than those of MS strains. No staphylococcal strain was resistant to vancomycin or linezolid. The resistance rate of E. faecalis strains to most of the drugs tested was much lower than those ofE. faecium. Some strains orE. faecium and E.faecalis were found resistant to vancomycin and linezolid. Regarding non-meningitis S. pneumoniae strains, the rate of PISP and PRSP were high. Strains of Enterobacteriaceae were highly susceptible to imipenem and meropenem, the overall resistance rates being less than 1.0%. Resistance rates of P aeruginosa to imipenem and meropenem were 20.2% and 18.2%, respectively. The resistance rates of A. baumanii to the two carbapenems were 52.1% and 48.3%, respectively. The prevalence of multi-drug resistant K. pneumoniae and A. baumanii increased markedly. Conclusion Bacterial resistance is on the rise, especially the incidence of multi-drug resistant organisms, which has become a major challenge to medical clinics.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2014年第5期338-343,共6页 Chinese Journal of Antibiotics
基金 国家临床重点专科建设项目经费 财社(2010)305号
关键词 细菌耐药性监测 细菌药物敏感试验 多重耐药菌 Bacterial resistance surveillance Bacterial susceptibility testing Multi-drug resistant bacteria
  • 相关文献

参考文献6

  • 1Martins A, Hunyadi A, Amaral L. Mechanisms of resistance in bacteria: an evolutionary approach[J]. Open MicrobiolJ, 2013, 7: 53-58.
  • 2肖永红,沈萍,魏泽庆,陈云波,孔海深,杨青,张伟丽,陈晓,李兰娟.Mohnarin 2011年度全国细菌耐药监测[J].中华医院感染学杂志,2012,22(22):4946-4952. 被引量:367
  • 3胡付品,朱德妹,汪复,蒋晓飞,杨青,徐英春,张小江,孙自镛,陈中举,王传清,王爱敏,倪语星,孙景勇,俞云松,林洁,单斌,杜艳,徐元宏,沈继录,张泓,孔菁,卓超,苏丹虹,张朝霞,季萍,胡云建,艾效曼,黄文祥,贾蓓,魏莲花,吴玲.2011年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2012,12(5):321-329. 被引量:529
  • 4Yang Q W, Wan g H , Sun H L, et al. Phenotypic and genotypic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems: result s from large hospital based surveillance studies in China[J]. Antimicrob Agents Chemother, 2010, 54(1): 573-577.
  • 5Davies J, Davies D. Origins and evolution of antibiotic resistance[J]. Microbiol Mol Biol Rev, 2010, 74(3): 417-433.
  • 6Pourakbari B, Aghdam M K, Mahmoudi S, et al. High frequency of vancomycin-resistant Enterococcus faecalis in an Iranian referral children medical hospital[J] Maedica(Buchar), 2012, 7(3): 201-204.

二级参考文献11

  • 1XIONG Zi-zhong ZHU De-mei WANG Fu ZHANG Ying-yuan.CTX-M-14, CTX-M-24 and resistance in Escherichia coli and Klebsiella pneumoniae clinical isolates[J].Chinese Medical Journal,2006(2):160-164. 被引量:13
  • 2Arias CA, Murray BE. Antibiotic-resistant bugs in the 21st century-a clinical super-challenge[J]. N Engl J Med, 2009, 360(5) : 439-443.
  • 3Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Tweenty-first in- formational supplement, 2011, M100-S21 Vol 31 No. 1.
  • 4Falagas ME, Giannopoulou KP, Kokolakis GN, et al. Fosfo- mycin: use beyond urinary tract and gastrointestinal infec tions[J]. Clin Infect Dis, 2008, 46(7): 1069-1077.
  • 5Olsson-Liljequist B, Burman LG. Introducing fosfomycin for surgical prophylaxis-emergence of resistance in aerobic faecal gram-negative bacteria of in patients, but not among strains causing infection after elective colorectal procedures [J ]. Scand J Infect Dis, 1993, 25(6) :725-733.
  • 6Andaker L, Burman LG, Eklund A, et al. Fosfomycin/met- ronidazole compared with doxycycline/metronidazole for the prophylaxis of infection after elective coloreetal surgery: a randomised double blind multicentre trial in 517 patients[J]. Eur J Surg, 1992, 158(3):181 185.
  • 7Nohr M, Andersen JC, Juul-Jensen KE. Prophylactic single dose fosfomycin and metronidazole compared with neomycin, haeitraein, metronidazole and ampicillin in elective colorectal operations[J]. Acta Chir Seand, 1990, 156(3):223-230.
  • 8Lindhagen J, Hadziomerovic A, Nordlung S, et al. Comparison of systemic prophylaxis with metronidazole-fosfomycin and met- ronidazole-cephalothin in elective colorectal surgery[J]. Acta Chir Scand, 1981, 147(4):277-283.
  • 9赵彩芸,肖永红,王珊,李耘,刘健,杨维维,郝凤兰.临床分离耐甲氧西林金黄色葡萄球菌染色体mec盒基因的分型[J].中华传染病杂志,2007,25(10):611-616. 被引量:23
  • 10汪复,朱德妹,胡付品,阮斐怡,倪语星,孙景勇,徐英春,孙宏莉,胡云健,艾效曼,俞云松,杨青,孙自镛,简翠,贾蓓,黄文祥,卓超,苏丹虹,魏莲花,吴玲,张朝霞,季萍,王传清,薛建昌,张泓,李万华.2007年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2008,8(5):325-333. 被引量:307

共引文献870

同被引文献117

  • 1潘树根,杨银梅,郭海波.肺炎链球菌对大环内酯-林可酰胺-链阳菌素的耐药监测及耐药机制研究[J].分子诊断与治疗杂志,2009,1(4):238-240. 被引量:2
  • 2黄道秋,李建英,陈联.重庆万州地区临床常见病原菌的耐药性分析及抗菌药的合理选用[J].药学服务与研究,2006,6(4):267-270. 被引量:2
  • 3徐光英,吴清.2023例细菌培养及耐药分析[J].重庆医学,2006,35(17):1564-1566. 被引量:6
  • 4应春妹,翁文浩.鲍曼不动杆菌多重耐药机制研究进展[J].检验医学,2007,22(2):208-212. 被引量:68
  • 5卫生部,国家中医药管理局.抗菌药物临床应用指导原则[S].2004:8~19
  • 6卫生部.2011年全国抗菌药物临床应用专项整治活动方案[S].北京:中华人民共和国卫生部,2011:56.
  • 7Yao KH,Yang YH.Streptoeoeeus pneumonia diseases in Chinese children: past, present and future[J].Vaccin, 2008,26 (35) : 4425-4433.
  • 8Brandon M,Dowzicky MJ.Antimicrobial susceptibility among Gram- positive organisms collected from pediatric patients globally between 2004 and 2011:results from the Tigecycline Evaluation and Surveil- lance Trial[J].J Clin Microbiol, 2013,51 (7) : 2371-2378.
  • 9Izdebski R,Rutschmann J,Fiett J,et al.Highly variable penicillin- resistance determinants PBP 2x,PBP 2b,and PBP la in isolates of two Streptococcus pneumonia clonal groups,poland 23F-16 and poland 613-20[J].Antimicrob Agents Chemother, 2008 (52) : 1021 - 1 027.
  • 10Mosleh MN,Gharibi M,Alikhani MY,et al.Antimicrobial suscepti- bility and analysis of macmlide resistance genes in Streptococcus pneu- moniae isolated in Hamadan[J].Iran J Basic Med Sci,2014,17(8):595- 599.

引证文献15

二级引证文献92

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部